Lv52
801 积分 2021-05-10 加入
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
18小时前
待确认
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer
9天前
已完结
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer
12天前
已完结
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer
12天前
已完结
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer
13天前
已完结
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
15天前
已完结
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
15天前
已完结
Mass-spectrometry-based draft of the human proteome
4个月前
已完结
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
4个月前
已完结
Replacing the tropolonic methoxyl group of colchicine with methylamino increases tubulin binding affinity with improved therapeutic index and overcomes paclitaxel cross-resistance
5个月前
已完结
皖公网安备34019202002308
